Form 4 for NXL Nexalin Technology, Inc.
Accepted 2025-09-30 00:00:00 ET · period of report 2025-09-29 · accession 0001829126-25-007777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 2025-09-29 | NXL | Owens David | Chief Medical Off, Dir | A - Grant | $0.00 | +36.5K | 191.3K | +24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2025-09-29 | A | A | 36,459 | $0.00 | 191,252 | D | — | — |